Sight Sciences outlines $82M-$88M 2026 revenue target while expanding interventional dry eye strategy
Source: SeekingAlpha
2026-03-04 19:02:59 ET
More on Sight Sciences
- Sight Sciences, Inc. (SGHT) Q4 2025 Earnings Call Transcript
- Sight Sciences: Improving Medicare Coverage Drives Eye-Popping Price Surge
- Sight Sciences GAAP EPS of -$0.08 beats by $0.07, revenue of $20.4M beats by $0.06M
- From REITs to Retail: Small caps with the longest runs at bullish Quant ratings
- Seeking Alpha’s Quant Rating on Sight Sciences
Read the full article on Seeking Alpha
For further details see:
Sight Sciences outlines $82M–$88M 2026 revenue target while expanding interventional dry eye strategy
Sight Sciences Inc.
NASDAQ: SGHT
SGHT Trading
8.83% G/L:
$3.945 Last:
281,966 Volume:
$3.61 Open:
SGHT Latest News
SGHT Stock Data
$305,334,247
36,534,366
18.49%
29
N/A
Medical Equipment & Supplies
Healthcare
US
Menlo Park
